This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Varat, M. A. Articles by Mercer, D. W. Search for Related Content PubMed PubMed Citation Articles by Varat, M. A. Articles by Mercer, D. W. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Heart Attack

Circulation, Vol 51, 855-859, Copyright © 1975 by American Heart Association

ARTICLES

Cardiac specific creatine phosphokinase isoenzyme in the diagnosis of acute myocardial infarction

MA Varat and DW Mercer

The specific and sensitivity of serum creatine phosphokinase cardiac specific isoenzyme (MB) in the diagnosis of acute myocardial infarction (AMI) was evaluated. An ion-exchange chromatographic technique was used to isolate MB. Sera layered on mini-columns of DEAE-Sephadex were eluted with Tris-buffered sodium chloride. Quantification of isolated MB was performed by creatine phosphokinase (CPK) assay (Rosalki method) of column effluents. MB was expressed as a percentage of the simultaneously determined total serum CPK; MB was determined in 100 consecutive admissions to the Coronary Care Unit. Acute myocardial infarction was diagnosed by accepted criteria. In 47 patients with proven AMI, including three with normal total CPK, peak MB was greater than 4% of total CPK. In 49 patients without AMI, including 15 with elevated total CPK (due to trauma, injections, cardioversion), peak MB was less than 2% of total CPK. MB was elevated, but did not peak in four patients without AMI but with chronic atrial fibrillation. Isolation and quantification of MB by this technique is rapidly and easily performed and provides a specific and extremely sensitive tool for the diagnosis of AMI.

This article has been cited by other articles:

				R. Rej They Use Enzymes for Everything! Clin. Chem., June 1, 1998; 44(6): 1149 - 1153. [Full Text] [PDF]

				A. E. Abdelmeguid, E. J. Topol, P. L. Whitlow, S. K. Sapp, and S. G. Ellis Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary Interventions Circulation, October 1, 1996; 94(7): 1528 - 1536. [Abstract] [Full Text]